Drugs Made In America Acquisition II Corp. UnitDMIIU

$10.12-0.02 (-0.20%)
NASDAQFinancial Services24:00 UTC

Company snapshot

10-Year Price
+2%
2025 — today
52-Week Range
$9.95$10.23
Current $10.12· 61%

DMIIU is a Special Purpose Acquisition Company (SPAC), operating as a blank check firm established in the Cayman Islands. Its core objective is to identify and complete a merger or acquisition with an existing business. The company specifically aims to acquire targets within the pharmaceutical and drug industries, driven by the goal of reducing the United States' reliance on international drug manufacturing. Each investment unit comprises one common stock share and an associated right, which entitles the holder to an additional one-tenth of a share once a suitable business combination is successfully finalized.

Valuation in context

No metrics available yet for DMIIU.

Free · No credit card needed

Get alerted when DMIIU is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.